100 years of serving patients: our Gödöllő plant, near Budapest celebrates a century of history
May 16, 2024 |
CORPORATE
Sixteen years ago, we took over the legacy of a pioneering vaccines and blood derivatives company in Hungary
Kedrion announces RYPLAZIM® now available in US
May 03, 2024 |
CORPORATE
Distribution resumes of medicine to treat Congenital Plasminogen Deficiency
The President and CEO of PPTA visits the Bolognana plant
Mar 11, 2024 |
CORPORATE
The meeting was a valuable opportunity for Kedrion and PPTA to strengthen our ongoing partnership
Kedrion reinforces its commitment against Rabies
Dec 07, 2023 |
CORPORATE
Agreement with Kamada to continue to serve patients exposed to the Rabies virus in the US and add potential territories
KEDPLASMA announces nationwide facility remodeling project
Nov 02, 2023 |
CORPORATE
The initiative aims at enhancing the experience of its donors who stand at the beginning of a bridge between patients and their care
Kedrion attended the 75th Annual Bleeding Disorders Conference in the US
Aug 25, 2023 |
CORPORATE
The company supported the Plasminogen Deficiency Foundation in a round-table for patients with Congenital Plasminogen Deficiency